Trial Profile
Open-label study of sofosbuvir with pegylated interferon and ribavirin in patients with genotype 1 Hepatitis C virus infection
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 28 Nov 2015
Price :
$35
*
At a glance
- Drugs Sofosbuvir (Primary) ; Ribavirin
- Indications Hepatitis C
- Focus Therapeutic Use
- 28 Nov 2015 New trial record